Evaluating endomyocardial biopsy and tailored treatments for pediatric inflammatory heart disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the role of endomyocardial biopsy (EMB) and aetiology-based treatments in pediatric patients with inflammatory heart disease, particularly focusing on myocarditis and its arrhythmic manifestations. It includes both retrospective and prospective phases, collecting clinical data before and after the diagnosis of myocarditis. The study aims to compare EMB with noninvasive diagnostic techniques and assess blood biomarkers for various clinical outcomes. Additionally, it seeks to describe the presentation of myocarditis with arrhythmias and evaluate healing times across different patient subgroups.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Written informed consent.
* Age \< 18 years.
* Clinically suspected myocarditis.
* Enrollment performed by one of the participating Centers.

Exclusion Criteria:

* Absence of written informed consent.
* Age \> 18 years (adults)

Where it's running

• IRCCS San Raffaele Scientific Institute
  Milan, Milano, Italy Recruiting

Study contacts

• Study coordinator: Giovanni Peretto, MD
• Email: peretto.giovanni@hsr.it
• Phone: +39 0226437482

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating endomyocardial biopsy and tailored treatments for inflammatory heart disease

  This study is trying to see if a heart tissue test and personalized treatments can help people with inflammatory heart disease, especially those with myocarditis and heart rhythm issues.

  Recruiting Scientific Institute San Raffaele · Milan, Milano · NCT04521790

• Colchicine treatment for chronic inflammatory cardiomyopathy

  This study tests if colchicine can help people with chronic inflammatory cardiomyopathy who have heart issues feel better by reducing inflammation in their hearts.

  Recruiting at 10 sites Phase 3 Niguarda Hospital · Naples, Campania and 9 other locations · NCT06158698

• Registry and biobank for arrhythmogenic ventricular cardiomyopathy

  This study is trying to gather information and samples from people with arrhythmogenic ventricular cardiomyopathy and their families to better understand the genetic causes of the condition and improve early diagnosis for those at risk.

  Recruiting at 2 sites Mayo Clinic · Rochester, Minnesota and 1 other locations · NCT03049254

• RHYthm and Myocardial Function Relationship in Heart Disease

  This study tests how heart rhythm patterns relate to heart muscle function in adults with arrhythmias or cardiomyopathy.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07491237

• Electrophysiological mapping to predict sudden cardiac death risk

  It will test whether detailed electrical mapping of the left ventricle can better predict dangerous ventricular arrhythmias in adults with ischemic or non-ischemic cardiomyopathy and LVEF under 50% who are not already ICD candidates.

  Recruiting at 3 sites University Hospital, Bordeaux · Clermont-Ferrand and 2 other locations · NCT07020702

• Predicting Ventricular Tachycardias in Patients After Myocarditis

  This study is trying to see if the amount of scar tissue in the hearts of people who have recovered from myocarditis can help predict their risk of serious heart problems like sudden cardiac death or fast heartbeats.

  Recruiting at 3 sites Centro Medico Teknon · Rozzano, Milan and 2 other locations · NCT06730607

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.